MDOBX
Price
$10.77
Change
+$0.02 (+0.19%)
Updated
Jun 26 closing price
Net Assets
42.1M
RNWHX
Price
$87.45
Change
+$0.90 (+1.04%)
Updated
Jun 26 closing price
Net Assets
68.99B
Interact to see
Advertisement

MDOBX vs RNWHX

Header iconMDOBX vs RNWHX Comparison
Open Charts MDOBX vs RNWHXBanner chart's image
Morgan Stanley Developing Opportunity C
Price$10.77
Change+$0.02 (+0.19%)
VolumeN/A
Net Assets42.1M
American Funds New World R5E
Price$87.45
Change+$0.90 (+1.04%)
VolumeN/A
Net Assets68.99B
MDOBX vs RNWHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MDOBX vs. RNWHX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDOBX is a StrongBuy and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 69B vs. MDOBX (42.1M). RNWHX pays higher dividends than MDOBX: RNWHX (1.04) vs MDOBX (0.00). MDOBX was incepted earlier than RNWHX: MDOBX (5 years) vs RNWHX (10 years). MDOBX (3.10) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 37.00 vs. MDOBX (29.00). RNWHX has a lower initial minimum investment than MDOBX: RNWHX (250) vs MDOBX (1000). MDOBX annual gain was more profitable for investors over the last year : 19.31 vs. RNWHX (11.19). RNWHX return over 5 years is better than : 35.11 vs. MDOBX (2.87).
MDOBXRNWHXMDOBX / RNWHX
Total Expense Ratio2.250.72313%
Annual Report Gross Expense Ratio3.100.72431%
Fund Existence5 years10 years-
Gain YTD12.21315.03681%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets42.1M69B0%
Annual Yield % from dividends0.001.04-
Returns for 1 year19.3111.19173%
Returns for 3 years34.5435.3598%
Returns for 5 years2.8735.118%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADIL0.470.24
+104.88%
Adial Pharmaceuticals
SKYE4.250.56
+15.18%
Skye Bioscience
OVV38.730.73
+1.92%
Ovintiv
MPW4.500.05
+1.12%
Medical Properties Trust
PRA22.880.03
+0.13%
ProAssurance Corp